Traiisdermal hormone replacement therapy, serum lipids and lipoproteins

British Journal of Clinical Practice

Volumn , Issue SUPPL. 86, 1996, Pages 17-21

  Crook, D ^a   Stevenson, J C ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LIPID; LIPOPROTEIN;

BLOOD; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MENOPAUSE; MIDDLE AGED; REVIEW;

ADMINISTRATION, CUTANEOUS; CORONARY DISEASE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MENOPAUSE; MIDDLE AGED;

EID: 0030227385     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bush TL, Barrett-Connor E, Cowan LD et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75:1102-1109.
2. Gruchow HW, Anderson AJ, Barboriak JJ et al. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J1988; 115: 954-963.
3. Stevenson JC, Crook D, Godsland IF et al. HRT and the cardiovascular system: non-lipid effects. Drugs 1994; 47: 35-41.
4. Havel RJ. Analysis of angiographie trial data in women. Drugs 1994; 47: 11-15.
5. Utermann G. The mysteries of lipoprotein (a). Science 1989; 264: 904-910.
6. Krauss RM. The tangled web of coronary risk factors. Am J Med 1991 ; 90(2A): 36s-41 s.
7. Regnstrom J, Nilsson J, Tornvall P et al. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. LanceM992; 339:1183-1186.
8. Bengttsson C, Bjorklund C, Lapidus L, Lissner L Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow-up of participants in prospective population study in Gothenburg, Sweden. B/WJ1993; 307: 1385-1388.
9. Gordon DJ, Rifkind BM. High-density lipoprotein the clinical implications of recent studies. N EnglJMed 1989; 321: 1311-1316.
10. Jacobs DR, Mebane IL, Bangidwala SI et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics prevalence study. Am J Epidemiol 1990; 131: 32-47.
11. Silverman DI, Ginsburg GS, Pasternak RC. Highdensity lipoprotein subfractions. Am J Med 1993; 94: 636-645.
12. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischémie heart disease and coronary atherosclerosis. Am Heart J 1987; 113:589-597.
13. Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoproteins and coronary atherosclerosis. Arteriosclerosis Thromb 1991; 11: 174-182.
14. Drexel H, Amann FW, Rentsch K et al. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Card/o/1992; 70: 436-440.
15. Seed M, Crook D. Hormone replacement therapies, cardiovascular disease and plasma lipoproteins. Curr Opinion Lipidology 1994; 5: 48-58.
16. Stevenson JC, Crook D, Godsland IF. Effects of age and menopause on lipid metabolism in healthy women. Atherosclerosis 1993; 98: 83-90.
17. Crook D, Stevenson JC, Whitehead Ml. Hormone replacement therapy and cardiovascular disease: ef-fects on plasma lipid risk markers. In: Swartz DP (ed). Hormonal Replacement Therapy. Baltimore, USA, Willliams and Wilkins, 1992: 139-170.
18. Stanczyk FZ, Shoupe D, Nunez V et al. A randomised comparison of non oral estradiol delivery in postmenopausal women. Am J Obstet Gynecol 1988; 159: 1540-1546.
19. Pattison NS, Uptin T, Knox B, France J. Transdermal oestrogen for postmenopausal women: a double-blind crossover comparative study with ethinyl oestradiol. Aust NZ J Obstet Gynaecol 1989; 29: 62-65.
20. Cortellaro M, Nencioni T, Boschetti C et al. Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment. Eur J Clin Pharmacol 1991; 41: 555-559.
21. Walsh BW et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Eng J Med 1991 ; 325: 1196-1204.
22. Adami S, Rossini M, Zamberlan N étal. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women. Mafur/fas1993;17: 191-196.
23. Mattsson LA, Samsioe G, von Schoultz B et al. Transdermally administered oestradiol combined with oral medroxyprogesterone acetate: the effect on lipoprotein metabolism in postmenopausal women. Br J Obstet Gynaeco/1993; 100: 450-453.
24. Pang SC, Greendale GA, Cedars Ml et al. Longterm effects of transdermal estradiol with and without medroxyprogesterone acetate: Fertil Steril 1993; 59: 76-82.
25. Slowinska-Srzednicka J, Zgliczynski A, Chotkowski E et al. Effect of transdermal 17-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women. J Intern Med 1993; 234: 447-451.
26. Erkkola R, Hirvonen E, Juntenen K et al. One year metabolic effects of transdermal or oral hormone replacement therapy. Eur J Menopause 1995; 2: 21-7.
27. Crook D, Cust MP, Gangar KF et al. Comparison of transdermal and oral estrogen/progestin hormone replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 1992; 166: 950-955.
28. Lindgren R, Berg G, Hammar M et al. Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate. Eur J Obstet Gynecol Reprod Biol 1992; 47: 213-221.
29. Keller PJ, Hotz E, Imthurn B. A transdermal regimen for continuous combined hormone replacement therapy in the menopause. Maturitas 1992; 15: 195-198.
30. Sack MN, Rader DJ, O'Cannon R. Oestrogen and inhibition of oxidation of low-density lipoproteins in post-menopausal women. Lancet 1994; 343:269-270.
31. Whitcroft S, Crook D, Ellerington ME et al. Longterm effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Obstet Gynecol 1994; 84: 222-226.
32. Durrington P. Summary and BHA guidelines. In: Laker M, Neil A, Wood C (eds). Cholesterol-lowering trials. London, Royal College of Physicians 1993:105-115.
33. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015-3023.
34. Glueck CJ, Lang J, Hamer T, Tracy T. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994; 123: 59-64.